Irritability

23 registered clinical trials studyying Irritability — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors NCT07469215	Fundació Sant Joan de Déu	N/A
Recruiting	Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants NCT06871488	Milton S. Hershey Medical Center	Phase 4
Recruiting	Fluoxetine on Emotional Experience (FLEX) Study NCT07424781	University of Oxford	N/A
Recruiting	Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers NCT06484088	National Institute of Mental Health (NIMH)	EARLY_Phase 1
Recruiting	Implementation of the Pain and Irritability of Unknown Origin (PIUO) Pathway in Community Pediatric Practices NCT06869928	University of British Columbia	N/A
Recruiting	AP Metabolism Transcriptomics NCT06814314	IRCCS Eugenio Medea	—
Recruiting	Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) NCT04619862	University of British Columbia	Phase 2
Active Not Recruiting	Behavior Therapy for Irritability in Autism NCT04654260	Yale University	N/A
Unknown	Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Serv NCT04632082	Hospital de Clinicas de Porto Alegre	N/A
Completed	Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease NCT03854019	The University of Texas Health Science Center, Houston	Phase 3
Completed	Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescent NCT03238118	Hospital de Clinicas de Porto Alegre	N/A
Completed	Pain and Irritability in Non-Verbal Children NCT03464773	University of British Columbia	N/A
Recruiting	Psychological Treatments for Youth With Severe Irritability. NCT02531893	National Institute of Mental Health (NIMH)	—
Completed	Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism NCT02552147	Yale University	Phase 1
Completed	Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents NCT01965184	Yale University	N/A
Completed	Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and NCT01942785	H. Lundbeck A/S	Phase 3
Withdrawn	Treatment Resistant Epilepsy and N-Acetyl Cysteine NCT02054949	Nationwide Children's Hospital	N/A
Completed	Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood NCT01508741	University of Hawaii	N/A
Unknown	Safety and Efficacy Study of Gamaline+Hipericin in PMS NCT01283568	Phytopharm Consulting Brazil	—
Completed	Safety and Immunogenicity Assessment of Rotavin-M1 in Vietnamese Children NCT01502969	National Institute of Hygiene and Epidemiology, Vietnam	Phase 2 / Phase 3
Completed	A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants NCT01377571	National Institute of Hygiene and Epidemiology, Vietnam	Phase 2
Completed	Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults NCT01375907	National Institute of Hygiene and Epidemiology, Vietnam	Phase 1
Unknown	Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms NCT00866411	Brooke Army Medical Center	N/A